Skip to main content
Abrdn PLC logo

Abrdn PLC — Investor Relations & Filings

Ticker · ABDN ISIN · GB00BF8Q6K64 LEI · 0TMBS544NMO7GLCE7H90 IL Financial and insurance activities
Open in API
Filings indexed 4,552 across all filing types
Latest filing 2023-08-15 Transaction in Own Shar…
Country GB United Kingdom
Listing IL ABDN

About Abrdn PLC

https://www.abrdn.com/en-gb

Abrdn PLC is a global investment company and asset manager formed from the 2017 merger of Standard Life and Aberdeen Asset Management. The firm offers a range of investment solutions, funds, and investment trusts. It serves a diverse client base that includes individual customers, financial advisers, wealth managers, and institutional investors. The company focuses on providing expertise and tools to help clients manage and grow their wealth, enabling them to prepare for their financial future.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document text explicitly states the subject matter in the title: "Transactions in own shares". It details the purchase of ordinary shares on the London Stock Exchange by abrdn plc on 14 August 2023, including volume, prices, and a list of individual transactions. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities.
2023-08-15 English
Form 8.3 - Dechra Pharmaceuticals PLC
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offer for 'Dechra Pharmaceuticals PLC'. This type of mandatory disclosure related to takeover activity and insider/significant shareholder dealings is a specific regulatory filing. While it relates to director/insider dealings (DIRS), the specific context of a Takeover Code disclosure (Form 8.3) makes it a specialized regulatory announcement. Since there is no specific code for 'Takeover Disclosure', and it is a mandatory regulatory filing disseminated via RNS, it falls best under the general 'Regulatory Filings' (RNS) category, as it is not a Director's Dealing report (DIRS) which typically refers to Form 3/4/5 filings under SEC rules, nor is it a general announcement of management changes or dividends. Given the structure and content, RNS is the most appropriate general regulatory classification for this specific UK Takeover Panel filing.
2023-08-14 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document is an RNS (Regulatory News Service) announcement from abrdn PLC, dated 14 August 2023. The title and content explicitly state 'Transactions in own shares' and detail the purchase of ordinary shares on the London Stock Exchange, including volume, price, and individual transaction logs. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is an RNS announcement, the specific content is about share repurchase, making POS the most accurate classification over the general RNS fallback.
2023-08-14 English
Form 8.3 - Dechra Pharmaceuticals PLC
Major Shareholding Notification Classification · 93% confidence The document explicitly states it is a 'FORM 8.3' concerning 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This form relates to dealings and holdings during a takeover situation involving 'Dechra Pharmaceuticals PLC'. This type of filing, which reports insider/significant shareholder transactions related to a takeover bid, is a specific type of regulatory disclosure. While it involves director/insider dealings (DIRS) and M&A activity (TAR), the specific format (Form 8.3) and context (Takeover Code disclosure) strongly align with filings related to significant shareholdings and transactions during a bid. However, none of the provided codes perfectly match 'Form 8.3'. Let's evaluate the closest fits: 1. DIRS (Director's Dealing): This is broader, usually covering routine insider trades, not specifically takeover-related Form 8.3s. 2. TAR (M&A Activity): This covers the proposal/bid itself, not necessarily the subsequent disclosure of holdings by interested parties. 3. MRQ (Major Shareholding Notification): This is for crossing general thresholds, not specifically takeover-related disclosures. 4. RNS (Regulatory Filings): This is the general fallback for miscellaneous regulatory announcements. Form 8.3 is a mandatory disclosure under the UK Takeover Code. Since there is no specific code for 'Takeover Disclosure Form 8.3', and this is a formal regulatory filing disseminated via RNS, the most appropriate classification among the given options, especially considering the nature of mandatory regulatory reporting that doesn't fit the specific financial/corporate action categories, is the general regulatory fallback category. If 'DIRS' were interpreted broadly to include all insider/significant holder transactions, it might fit, but 'Form 8.3' is highly specific to takeover activity. Given the options, RNS serves as the best catch-all for specific, non-standard regulatory forms.
2023-08-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (RNS Number : 9963I) from abrdn PLC dated 11 August 2023. The title and content explicitly state 'Transactions in own shares' and detail the purchase of ordinary shares on the London Stock Exchange, including volume, price, and individual transaction references. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities.
2023-08-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from abrdn PLC dated 10 August 2023. The title and content explicitly state 'Transactions in own shares' and detail the purchase of ordinary shares on the London Stock Exchange, including volume, price, and individual transaction logs. This directly corresponds to the definition of a 'Transaction in Own Shares' report, which has the code POS.
2023-08-10 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.